Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 2/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.56 |
| ▸ | PPARD | Q03181 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | KRAS | P01116 | 1/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | F3 | P13726 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12464057 | 0.90 | PPARA (0.71) | PPARAPPARGPPARD | |
| SCHEMBL12965011 | 0.89 | PPARA (0.55) | PPARAPPARGPPARDMAOBKRAS | |
| SCHEMBL2598006 | 0.86 | MAOB (0.51) | MAOB | |
| SCHEMBL2598005 | 0.86 | MAOB (0.51) | MAOB | |
| SCHEMBL12186106 | 0.86 | PPARA (0.54) | PPARAPPARGPPARDMAOBCYP1A1 | |
| SCHEMBL29138462 | 0.84 | PPARD (0.49) | PPARAPPARGPPARDMAOBCYP1A1 | |
| SCHEMBL20932824 | 0.81 | PPARG (0.80) | PPARAPPARGPPARD | |
| SCHEMBL2647392 | 0.80 | CYP2D6 (0.63) | MAOBCYP1A1CYP1B1F3CYP2D6 | |
| SCHEMBL2648722 | 0.79 | MAOB (0.69) | MAOBCYP1A1CYP1B1F3CYP2D6 | |
| SCHEMBL2665078 | 0.79 | MAOB (0.69) | MAOBCYP1A1CYP1B1F3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113677336-B | Combination therapy comprising a compound of formula (I) and a GLP-1 receptor agonist | 基恩菲特公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-109072302-B | Non-invasive diagnosis of non-alcoholic steatohepatitis | 基恩菲特公司 | 2024-01-16 | — | — | CN | disclosed |